Early evaluation of tumoral response to antiangiogenic therapy by arterial spin labeling perfusion magnetic resonance imaging and susceptibility weighted imaging in a patient with recurrent glioblastoma receiving bevacizumab. [electronic resource]
Producer: 20110628Description: e308-11 p. digitalISSN:- 1527-7755
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab
- Brain Neoplasms -- drug therapy
- Camptothecin -- administration & dosage
- Fatal Outcome
- Glioblastoma -- drug therapy
- Humans
- Irinotecan
- Magnetic Resonance Angiography
- Male
- Neoplasm Recurrence, Local -- drug therapy
- Spin Labels
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.